1 Inflammatory Bowel Disease Drugs Market Overview 1.1 Product Overview and Scope of Inflammatory Bowel Disease Drugs 1.2 Inflammatory Bowel Disease Drugs Segment by Type 1.2.1 Global Inflammatory Bowel Disease Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Amino-salicylates 1.2.3 Antibiotics 1.2.4 Corticosteroids 1.2.5 Immunomodulators 1.2.6 Biologics 1.2.7 Others 1.3 Inflammatory Bowel Disease Drugs Segment by Application 1.3.1 Global Inflammatory Bowel Disease Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Ulcerative Colitis 1.3.3 Crohns Disease 1.3.4 Indeterminate Colitis 1.3.5 Others 1.4 Global Inflammatory Bowel Disease Drugs Market Size Estimates and Forecasts 1.4.1 Global Inflammatory Bowel Disease Drugs Revenue 2016-2027 1.4.2 Global Inflammatory Bowel Disease Drugs Sales 2016-2027 1.4.3 Inflammatory Bowel Disease Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Inflammatory Bowel Disease Drugs Market Competition by Manufacturers 2.1 Global Inflammatory Bowel Disease Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Inflammatory Bowel Disease Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Inflammatory Bowel Disease Drugs Manufacturing Sites, Area Served, Product Type 2.5 Inflammatory Bowel Disease Drugs Market Competitive Situation and Trends 2.5.1 Inflammatory Bowel Disease Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Inflammatory Bowel Disease Drugs Players Market Share by Revenue 2.5.3 Global Inflammatory Bowel Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Inflammatory Bowel Disease Drugs Retrospective Market Scenario by Region 3.1 Global Inflammatory Bowel Disease Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Inflammatory Bowel Disease Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Inflammatory Bowel Disease Drugs Market Facts & Figures by Country 3.3.1 North America Inflammatory Bowel Disease Drugs Sales by Country 3.3.2 North America Inflammatory Bowel Disease Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Inflammatory Bowel Disease Drugs Market Facts & Figures by Country 3.4.1 Europe Inflammatory Bowel Disease Drugs Sales by Country 3.4.2 Europe Inflammatory Bowel Disease Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Inflammatory Bowel Disease Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Inflammatory Bowel Disease Drugs Sales by Region 3.5.2 Asia Pacific Inflammatory Bowel Disease Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Inflammatory Bowel Disease Drugs Market Facts & Figures by Country 3.6.1 Latin America Inflammatory Bowel Disease Drugs Sales by Country 3.6.2 Latin America Inflammatory Bowel Disease Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Inflammatory Bowel Disease Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Country 3.7.2 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Inflammatory Bowel Disease Drugs Historic Market Analysis by Type 4.1 Global Inflammatory Bowel Disease Drugs Sales Market Share by Type (2016-2021) 4.2 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Inflammatory Bowel Disease Drugs Price by Type (2016-2021) 5 Global Inflammatory Bowel Disease Drugs Historic Market Analysis by Application 5.1 Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2016-2021) 5.2 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Inflammatory Bowel Disease Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Abbott Laboratories 6.1.1 Abbott Laboratories Corporation Information 6.1.2 Abbott Laboratories Description and Business Overview 6.1.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Abbott Laboratories Inflammatory Bowel Disease Drugs Product Portfolio 6.1.5 Abbott Laboratories Recent Developments/Updates 6.2 Biocon Ltd 6.2.1 Biocon Ltd Corporation Information 6.2.2 Biocon Ltd Description and Business Overview 6.2.3 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Biocon Ltd Inflammatory Bowel Disease Drugs Product Portfolio 6.2.5 Biocon Ltd Recent Developments/Updates 6.3 Roche 6.3.1 Roche Corporation Information 6.3.2 Roche Description and Business Overview 6.3.3 Roche Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Roche Inflammatory Bowel Disease Drugs Product Portfolio 6.3.5 Roche Recent Developments/Updates 6.4 Johnson and Johnson 6.4.1 Johnson and Johnson Corporation Information 6.4.2 Johnson and Johnson Description and Business Overview 6.4.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Johnson and Johnson Inflammatory Bowel Disease Drugs Product Portfolio 6.4.5 Johnson and Johnson Recent Developments/Updates 6.5 Mylan Pharmaceuticals 6.5.1 Mylan Pharmaceuticals Corporation Information 6.5.2 Mylan Pharmaceuticals Description and Business Overview 6.5.3 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product Portfolio 6.5.5 Mylan Pharmaceuticals Recent Developments/Updates 6.6 Novartis AG 6.6.1 Novartis AG Corporation Information 6.6.2 Novartis AG Description and Business Overview 6.6.3 Novartis AG Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Novartis AG Inflammatory Bowel Disease Drugs Product Portfolio 6.6.5 Novartis AG Recent Developments/Updates 6.7 Pfizer 6.6.1 Pfizer Corporation Information 6.6.2 Pfizer Description and Business Overview 6.6.3 Pfizer Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Pfizer Inflammatory Bowel Disease Drugs Product Portfolio 6.7.5 Pfizer Recent Developments/Updates 6.8 Quest Medical 6.8.1 Quest Medical Corporation Information 6.8.2 Quest Medical Description and Business Overview 6.8.3 Quest Medical Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Quest Medical Inflammatory Bowel Disease Drugs Product Portfolio 6.8.5 Quest Medical Recent Developments/Updates 6.9 Sanofi 6.9.1 Sanofi Corporation Information 6.9.2 Sanofi Description and Business Overview 6.9.3 Sanofi Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Sanofi Inflammatory Bowel Disease Drugs Product Portfolio 6.9.5 Sanofi Recent Developments/Updates 6.10 Takeda Pharmaceutical 6.10.1 Takeda Pharmaceutical Corporation Information 6.10.2 Takeda Pharmaceutical Description and Business Overview 6.10.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product Portfolio 6.10.5 Takeda Pharmaceutical Recent Developments/Updates 7 Inflammatory Bowel Disease Drugs Manufacturing Cost Analysis 7.1 Inflammatory Bowel Disease Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs 7.4 Inflammatory Bowel Disease Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Inflammatory Bowel Disease Drugs Distributors List 8.3 Inflammatory Bowel Disease Drugs Customers 9 Inflammatory Bowel Disease Drugs Market Dynamics 9.1 Inflammatory Bowel Disease Drugs Industry Trends 9.2 Inflammatory Bowel Disease Drugs Growth Drivers 9.3 Inflammatory Bowel Disease Drugs Market Challenges 9.4 Inflammatory Bowel Disease Drugs Market Restraints 10 Global Market Forecast 10.1 Inflammatory Bowel Disease Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Inflammatory Bowel Disease Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Inflammatory Bowel Disease Drugs by Type (2022-2027) 10.2 Inflammatory Bowel Disease Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Inflammatory Bowel Disease Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Inflammatory Bowel Disease Drugs by Application (2022-2027) 10.3 Inflammatory Bowel Disease Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Inflammatory Bowel Disease Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Inflammatory Bowel Disease Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Inflammatory Bowel Disease Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Inflammatory Bowel Disease Drugs Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Inflammatory Bowel Disease Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Inflammatory Bowel Disease Drugs Covered in This Study Table 5. Global Inflammatory Bowel Disease Drugs Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Inflammatory Bowel Disease Drugs Sales Market Share by Manufacturers (2016-2021) Table 7. Global Inflammatory Bowel Disease Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Inflammatory Bowel Disease Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Inflammatory Bowel Disease Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Inflammatory Bowel Disease Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Inflammatory Bowel Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Inflammatory Bowel Disease Drugs Sales by Region (2016-2021) & (K Units) Table 16. Global Inflammatory Bowel Disease Drugs Sales Market Share by Region (2016-2021) Table 17. Global Inflammatory Bowel Disease Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Inflammatory Bowel Disease Drugs Sales by Country (2016-2021) & (K Units) Table 19. North America Inflammatory Bowel Disease Drugs Sales Market Share by Country (2016-2021) Table 20. North America Inflammatory Bowel Disease Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Inflammatory Bowel Disease Drugs Sales by Country (2016-2021) & (K Units) Table 23. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Inflammatory Bowel Disease Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Inflammatory Bowel Disease Drugs Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Inflammatory Bowel Disease Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Inflammatory Bowel Disease Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Inflammatory Bowel Disease Drugs Sales by Country (2016-2021) & (K Units) Table 31. Latin America Inflammatory Bowel Disease Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Inflammatory Bowel Disease Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Inflammatory Bowel Disease Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Inflammatory Bowel Disease Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Inflammatory Bowel Disease Drugs Sales (K Units) by Type (2016-2021) Table 39. Global Inflammatory Bowel Disease Drugs Sales Market Share by Type (2016-2021) Table 40. Global Inflammatory Bowel Disease Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Inflammatory Bowel Disease Drugs Revenue Share by Type (2016-2021) Table 42. Global Inflammatory Bowel Disease Drugs Price (USD/Unit) by Type (2016-2021) Table 43. Global Inflammatory Bowel Disease Drugs Sales (K Units) by Application (2016-2021) Table 44. Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2016-2021) Table 45. Global Inflammatory Bowel Disease Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Inflammatory Bowel Disease Drugs Revenue Share by Application (2016-2021) Table 47. Global Inflammatory Bowel Disease Drugs Price (USD/Unit) by Application (2016-2021) Table 48. Abbott Laboratories Corporation Information Table 49. Abbott Laboratories Description and Business Overview Table 50. Abbott Laboratories Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Abbott Laboratories Inflammatory Bowel Disease Drugs Product Table 52. Abbott Laboratories Recent Developments/Updates Table 53. Biocon Ltd Corporation Information Table 54. Biocon Ltd Description and Business Overview Table 55. Biocon Ltd Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Biocon Ltd Inflammatory Bowel Disease Drugs Product Table 57. Biocon Ltd Recent Developments/Updates Table 58. Roche Corporation Information Table 59. Roche Description and Business Overview Table 60. Roche Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Roche Inflammatory Bowel Disease Drugs Product Table 62. Roche Recent Developments/Updates Table 63. Johnson and Johnson Corporation Information Table 64. Johnson and Johnson Description and Business Overview Table 65. Johnson and Johnson Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Johnson and Johnson Inflammatory Bowel Disease Drugs Product Table 67. Johnson and Johnson Recent Developments/Updates Table 68. Mylan Pharmaceuticals Corporation Information Table 69. Mylan Pharmaceuticals Description and Business Overview Table 70. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product Table 72. Mylan Pharmaceuticals Recent Developments/Updates Table 73. Novartis AG Corporation Information Table 74. Novartis AG Description and Business Overview Table 75. Novartis AG Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Novartis AG Inflammatory Bowel Disease Drugs Product Table 77. Novartis AG Recent Developments/Updates Table 78. Pfizer Corporation Information Table 79. Pfizer Description and Business Overview Table 80. Pfizer Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Pfizer Inflammatory Bowel Disease Drugs Product Table 82. Pfizer Recent Developments/Updates Table 83. Quest Medical Corporation Information Table 84. Quest Medical Description and Business Overview Table 85. Quest Medical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Quest Medical Inflammatory Bowel Disease Drugs Product Table 87. Quest Medical Recent Developments/Updates Table 88. Sanofi Corporation Information Table 89. Sanofi Description and Business Overview Table 90. Sanofi Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Sanofi Inflammatory Bowel Disease Drugs Product Table 92. Sanofi Recent Developments/Updates Table 93. Takeda Pharmaceutical Corporation Information Table 94. Takeda Pharmaceutical Description and Business Overview Table 95. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product Table 97. Takeda Pharmaceutical Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Inflammatory Bowel Disease Drugs Distributors List Table 101. Inflammatory Bowel Disease Drugs Customers List Table 102. Inflammatory Bowel Disease Drugs Market Trends Table 103. Inflammatory Bowel Disease Drugs Growth Drivers Table 104. Inflammatory Bowel Disease Drugs Market Challenges Table 105. Inflammatory Bowel Disease Drugs Market Restraints Table 106. Global Inflammatory Bowel Disease Drugs Sales Forecast by Type (2022-2027) & (K Units) Table 107. Global Inflammatory Bowel Disease Drugs Sales Market Share Forecast by Type (2022-2027) Table 108. Global Inflammatory Bowel Disease Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 109. Global Inflammatory Bowel Disease Drugs Revenue Market Share Forecast by Type (2022-2027) Table 110. Global Inflammatory Bowel Disease Drugs Sales Forecast by Application (2022-2027) & (K Units) Table 111. Global Inflammatory Bowel Disease Drugs Sales Market Share Forecast by Application (2022-2027) Table 112. Global Inflammatory Bowel Disease Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 113. Global Inflammatory Bowel Disease Drugs Revenue Market Share Forecast by Application (2022-2027) Table 114. Global Inflammatory Bowel Disease Drugs Sales Forecast by Region (2022-2027) & (K Units) Table 115. Global Inflammatory Bowel Disease Drugs Sales Market Share Forecast by Region (2022-2027) Table 116. Global Inflammatory Bowel Disease Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 117. Global Inflammatory Bowel Disease Drugs Revenue Market Share Forecast by Region (2022-2027) Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Inflammatory Bowel Disease Drugs Figure 2. Global Inflammatory Bowel Disease Drugs Market Share by Type in 2020 & 2027 Figure 3. Amino-salicylates Product Picture Figure 4. Antibiotics Product Picture Figure 5. Corticosteroids Product Picture Figure 6. Immunomodulators Product Picture Figure 7. Biologics Product Picture Figure 8. Others Product Picture Figure 9. Global Inflammatory Bowel Disease Drugs Market Share by Application in 2020 & 2027 Figure 10. Ulcerative Colitis Figure 11. Crohns Disease Figure 12. Indeterminate Colitis Figure 13. Others Figure 14. Global Inflammatory Bowel Disease Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Inflammatory Bowel Disease Drugs Market Size 2016-2027 (US$ Million) Figure 16. Global Inflammatory Bowel Disease Drugs Sales 2016-2027 (K Units) Figure 17. Global Inflammatory Bowel Disease Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 18. Inflammatory Bowel Disease Drugs Sales Share by Manufacturers in 2020 Figure 19. Global Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers in 2020 Figure 20. The Global 5 and 10 Largest Inflammatory Bowel Disease Drugs Players: Market Share by Revenue in 2020 Figure 21. Inflammatory Bowel Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 22. Global Inflammatory Bowel Disease Drugs Sales Market Share by Region (2016-2021) Figure 23. Global Inflammatory Bowel Disease Drugs Sales Market Share by Region in 2020 Figure 24. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Region (2016-2021) Figure 25. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Region in 2020 Figure 26. U.S. Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Canada Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Germany Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. France Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. U.K. Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Italy Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Russia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Japan Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. South Korea Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. India Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Australia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Taiwan Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Indonesia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Thailand Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Malaysia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Philippines Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Vietnam Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Mexico Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Brazil Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Argentina Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Turkey Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Saudi Arabia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. U.A.E Inflammatory Bowel Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Sales Market Share of Inflammatory Bowel Disease Drugs by Type (2016-2021) Figure 51. Sales Market Share of Inflammatory Bowel Disease Drugs by Application (2016-2021) Figure 52. Sales Market Share of Inflammatory Bowel Disease Drugs by Application in 2020 Figure 53. Revenue Share of Inflammatory Bowel Disease Drugs by Application (2016-2021) Figure 54. Revenue Share of Inflammatory Bowel Disease Drugs by Application in 2020 Figure 55. Manufacturing Cost Structure of Inflammatory Bowel Disease Drugs Figure 56. Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs Figure 57. Inflammatory Bowel Disease Drugs Industrial Chain Analysis Figure 58. Channels of Distribution Figure 59. Distributors Profiles Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Abbott Laboratories Biocon Ltd Roche Johnson and Johnson Mylan Pharmaceuticals Novartis AG Pfizer Quest Medical Sanofi Takeda Pharmaceutical